Phase I Evaluation of the Pharmacokinetics and Safety of Boceprevir and Ucalm (St John's Wort) When Co-administered to Male and Female Healthy Volunteers.

Trial Profile

Phase I Evaluation of the Pharmacokinetics and Safety of Boceprevir and Ucalm (St John's Wort) When Co-administered to Male and Female Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jan 2013

At a glance

  • Drugs Boceprevir (Primary) ; Hypericum (Primary)
  • Indications Depressive disorders; Hepatitis C
  • Focus Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Aug 2012 New trial record
    • 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top